WJ doesn’t treat joint pain, but rather addresses the underlying structural tissue defect(s) that is often the primary culprit of joint pain.
WJ tissue is immune-privileged and tested extensively for communicable diseases, leading to a lower risk of adverse events. In 5 years of operation, Regenative Labs’ products have never incurred an adverse event.
When applied to defects in articular cartilage or other soft tissues, the collagen-based ECM provides tensile strength and protects surrounding tissues from mechanical stress. In addition, the ECM remains in the affected area long after application, providing a structural scaffold for the body’s natural healing process to unfold.